大悦城地產(00207.HK)附屬成都鵬悦向借款人提供5.8億元重續股東貸款
格隆匯 8 月 4日丨大悦城地產(00207.HK)發佈公告,有關公司的間接全資附屬公司成都鵬悦向借款人提供首筆股東貸款。由於全部首筆股東貸款於2020年8月已到期或將到期,2020年8月4日,成都鵬悦與借款人訂立補充協議,內容有關根據補充協議的條款及條件,按年利率10%向借款人提供總額為人民幣5.8億元的重續股東貸款。借款人主要從事開發昆明市西山區螺螄灣的城市棚户區,並由成都鵬悦及其他獨立第三方分別擁有其30%及70%股權,而成都鵬悦將按其於借款人的持股權益比例提供股東貸款。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.